156 related articles for article (PubMed ID: 35754823)
21. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness.
Segerberg F; Lundtoft C; Reid S; Hjorton K; Leonard D; Nordmark G; Carlsten M; Hagberg N
Front Immunol; 2019; 10():2164. PubMed ID: 31572377
[TBL] [Abstract][Full Text] [Related]
23. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
[TBL] [Abstract][Full Text] [Related]
24. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
Beigmohammadi F; Mahmoudi M; Karami J; Ahmadzadeh N; Ebrahimi-Daryani N; Rezaei N
J Immunol Res; 2020; 2020():4873648. PubMed ID: 33015197
[TBL] [Abstract][Full Text] [Related]
25. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
[TBL] [Abstract][Full Text] [Related]
26. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
27. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.
Varbanova VP; Mihailova S; Naumova E; Mihaylova AP
Turk J Haematol; 2019 Nov; 36(4):238-246. PubMed ID: 31337191
[TBL] [Abstract][Full Text] [Related]
28. Association of killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands with susceptibility to Behçet's disease.
Mohammad-Ebrahim H; Kamali-Sarvestani E; Mahmoudi M; Beigy M; Karami J; Ahmadzadeh N; Shahram F
Scand J Rheumatol; 2018 Mar; 47(2):155-163. PubMed ID: 28862099
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
[TBL] [Abstract][Full Text] [Related]
30. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
31. Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis.
Vigone B; Santaniello A; Marchini M; Montanelli G; Caronni M; Severino A; Beretta L
Rheumatology (Oxford); 2015 Apr; 54(4):707-11. PubMed ID: 25231181
[TBL] [Abstract][Full Text] [Related]
32. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
[TBL] [Abstract][Full Text] [Related]
33. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.
Vlachoyiannopoulos PG; Dafni UG; Pakas I; Spyropoulou-Vlachou M; Stavropoulos-Giokas C; Moutsopoulos HM
Ann Rheum Dis; 2000 May; 59(5):359-67. PubMed ID: 10784518
[TBL] [Abstract][Full Text] [Related]
34. KIR/HLA ligands immunogenetics markers associated with outcome of hepatitis B virus infection in the Bulgarian population.
Varbanova V; Popov G; Grigorova V; Petrova D; Naumova E; Mihaylova A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Sep; 165(3):270-276. PubMed ID: 32975242
[TBL] [Abstract][Full Text] [Related]
35. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
[TBL] [Abstract][Full Text] [Related]
36. Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.
Salim PH; Jobim M; Bredemeier M; Chies JA; Schlottfeldt J; Brenol JC; Jobim LF; Xavier RM
Clin Exp Immunol; 2010 Jun; 160(3):325-30. PubMed ID: 20082621
[TBL] [Abstract][Full Text] [Related]
37. Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos.
Garrido-Rodríguez D; Ávila-Ríos S; García-Morales C; Valenzuela-Ponce H; Ormsby C; Reyes-Gopar H; Fernandez-Lopez JC; Reyes-Terán G
Immunogenetics; 2016 Oct; 68(9):703-17. PubMed ID: 27240860
[TBL] [Abstract][Full Text] [Related]
38. Genetic Susceptibility to Systemic Sclerosis in the Greek-Cypriot Population: A Pilot Study.
Chairta P; Psarelis S; Michailidou K; Demetriou C; Symeonidou S; Nicolaou P; Christodoulou K
Genet Test Mol Biomarkers; 2020 May; 24(5):309-317. PubMed ID: 32315557
[No Abstract] [Full Text] [Related]
39. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases.
Kuwana M; Kimura K; Hirakata M; Kawakami Y; Ikeda Y
Ann Rheum Dis; 2002 Sep; 61(9):842-6. PubMed ID: 12176814
[TBL] [Abstract][Full Text] [Related]
40. Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. The United Kingdom Systemic Sclerosis Study Group.
Maddison PJ; Stephens C; Briggs D; Welsh KI; Harvey G; Whyte J; McHugh N; Black CM
Medicine (Baltimore); 1993 Mar; 72(2):103-12. PubMed ID: 8479323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
